Tag:
Guidant
Latest Headlines
Latest Headlines
Army doc to pay fine for accepting meals, cash from Guidant
An Army cardiologist will have to pay more than $12,700 in fines and restitution for accepting free meals and illegal payments from a Guidant Sales, a unit of Boston Scientific. Maj. Jason Layne
Justice sues Boston Sci over faulty defibrillators
The Justice Department is suing Boston Scientific and its Guidant unit under the False Claims Act for conduct related to the faulty heart devices Ventak Prizm 2 and the Renewal 1 and 2. The
Boston Sci division has DoJ, IRS woes
The U.S. government has changed its mind about a potential whistleblower case against Guidant, a division of Boston Scientific ( $BSX ). After refusing to step into a New York suit accusing Guidant of
Guidant's $296M 'landmark' plea rejected by judge
Guidant's proposed $296 million plea deal was rejected by a federal judge in Minneapolis Tuesday because it doesn't address "the criminal conduct at issue." The plea did not include corporate
Judge delays decision on Guidant-Justice settlement after plaintiffs cry foul
A federal judge Monday delayed a decision on whether to accept a $296 million plea agreement between the Justice Department and Guidant, a unit of Boston Scientific, that had been charged with
Report: Feds scrutinizing Boston Scientific recall
The Justice Department and the SEC are investigating Boston Scientific's recent recall of implantable heart defibrillators, The Wall Street Journal reports, citing an internal company memo. Although
Guidant charged for not reporting defibrillator problems
Guidant, a subsidiary of Boston Scientific, has been charged with concealing information regarding catastrophic failures in three models of implantable cardioverter defibrillators. The charges were
J&J CEO talks tech
What do you obsess about when you're CEO of Johnson & Johnson? Well, it's not Band-Aids. In an interview with the Financial Times, Bill Weldon ( photo ) admits to a fascination with technology.
ALSO NOTED: Viracept snafu costing Roche millions; Abraxis gets FDA nod for generic Ellence;
> Roche has lost some $85 million in Viracept sales since it pulled the drug off the European market in June for contamination. The company awaits the E.U.'s approval to begin selling the drug
Boston Scientific preps for big layoffs
Welcome to the wake , Boston Scientific. The device maker is poised to join its healthcare colleagues in laying off
